AU3425999A - Pharmaceutical compositions containing in combination an arginine-vasopressin v 1a antagonist and an angiotensin II at 1 receptor antagonist - Google Patents

Pharmaceutical compositions containing in combination an arginine-vasopressin v 1a antagonist and an angiotensin II at 1 receptor antagonist

Info

Publication number
AU3425999A
AU3425999A AU34259/99A AU3425999A AU3425999A AU 3425999 A AU3425999 A AU 3425999A AU 34259/99 A AU34259/99 A AU 34259/99A AU 3425999 A AU3425999 A AU 3425999A AU 3425999 A AU3425999 A AU 3425999A
Authority
AU
Australia
Prior art keywords
antagonist
vasopressin
angiotensin
arginine
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34259/99A
Inventor
Dino Nisato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU3425999A publication Critical patent/AU3425999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34259/99A 1998-04-29 1999-04-22 Pharmaceutical compositions containing in combination an arginine-vasopressin v 1a antagonist and an angiotensin II at 1 receptor antagonist Abandoned AU3425999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9805591 1998-04-29
FR9805591A FR2778103A1 (en) 1998-04-29 1998-04-29 PHARMACEUTICAL COMPOSITIONS CONTAINING IN ASSOCIATION A V1A ARGININE-VASOPRESSIN ANTAGONIST AND AN ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST
PCT/FR1999/000959 WO1999055340A1 (en) 1998-04-29 1999-04-22 PHARMACEUTICAL COMPOSITIONS CONTAINING IN COMBINATION AN ARGININE-VASOPRESSIN V1a ANTAGONIST AND AN ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST

Publications (1)

Publication Number Publication Date
AU3425999A true AU3425999A (en) 1999-11-16

Family

ID=9525979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34259/99A Abandoned AU3425999A (en) 1998-04-29 1999-04-22 Pharmaceutical compositions containing in combination an arginine-vasopressin v 1a antagonist and an angiotensin II at 1 receptor antagonist

Country Status (3)

Country Link
AU (1) AU3425999A (en)
FR (1) FR2778103A1 (en)
WO (1) WO1999055340A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR033390A1 (en) * 2000-08-22 2003-12-17 Novartis Ag A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ATTA RECEIVER ANTAGONIST AND A POTENTIATOR OF THE INSULIN SECRETION, THE USE OF SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND A PARTS KIT
US20060089389A1 (en) 2000-08-22 2006-04-27 Malcolm Allison Combination
WO2002043807A2 (en) * 2000-12-01 2002-06-06 Novartis Ag Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
ATE493973T1 (en) 2004-06-04 2011-01-15 Teva Pharma PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
FR2708606B1 (en) * 1993-07-30 1995-10-27 Sanofi Sa N-phenylalkylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
FR2740136B1 (en) * 1995-10-24 1998-01-09 Sanofi Sa INDOLIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO1999055340A1 (en) 1999-11-04
FR2778103A1 (en) 1999-11-05

Similar Documents

Publication Publication Date Title
HUP0102658A3 (en) Pharmaceutical composition containing opioid agonist and antagonist combination
HUP0201545A2 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
IS5594A (en) A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL118325A0 (en) Integrin receptor antagonists and pharmaceutical compositions containing them
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
IL139865A0 (en) A liver selective glucocorticoid antagonist and pharmaceutical compositions containing the same
HUP0100607A3 (en) Thrombin receptor antagonists and pharmaceutical compositions containing them
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
AU5565099A (en) Pharmaceutical compositions and methods for use
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0100680A3 (en) Indole derivatives and medicinal compositions containing the same
AU5901900A (en) Indole and indazole urea-peptoids as thrombin receptor antagonists
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
HUP9904301A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
AU5522399A (en) Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent
EP0838471A4 (en) Peptide derivatives and angiotensin iv receptor agonist
AU3425999A (en) Pharmaceutical compositions containing in combination an arginine-vasopressin v 1a antagonist and an angiotensin II at 1 receptor antagonist
AU5861900A (en) Receptor agonists and antagonists
GB9820014D0 (en) Receptor antagonists and uses thereof
HUP0001010A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
AU1392800A (en) Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant
ZA991765B (en) Pharmaceutical compositions containing in combination a selective V1a arginine vasopressin receptor antagonist and a selective V2 arginine vasopressin receptor antagonist.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase